Interventions for treating oral candidiasis for patients with cancer receiving treatment

Keyphrases

• Patients with Cancer 100%
• Oral Candidiasis 100%
• Clotrimazole 27%
• Oral Health 18%
• Chemotherapy 18%
• Radiotherapy 18%
• Placebo 18%
• High Dose 18%
• Cochrane 18%
• Health Groups 18%
• Ketoconazole 18%
• Randomized Controlled Trial 9%
• Cancer Treatment 9%
• Illness 9%
• Intervention Effectiveness 9%
• Quality Assessment 9%
• Inclusion Criteria 9%
• Systemic Infection 9%
• Relative Risk 9%
• Placebo-controlled Trial 9%
• MEDLINE 9%
• Embase 9%
• Issue 3 9%
• Random Effects Model 9%
• Patient Well-being 9%
• Length of Hospital Stay 9%
• Analgesia 9%
• Hospital Costs 9%
• Gastrointestinal Tract 9%
• Statistical Guidelines 9%
• Long-term Adverse Effects 9%
• Oral Side Effects 9%
• Dysphagia 9%
• New Intervention 9%
• Computer Search 9%
• Risk Value 9%
• Two-agent 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Thrush 100%
• Placebo 27%
• Clotrimazole 27%
• Chemotherapy 18%
• Side Effect 18%
• Ketoconazole 18%
• Randomized Controlled Trial 9%
• Random Effects Model 9%
• Dysphagia 9%
• Sepsis 9%
• Diseases 9%

Medicine and Dentistry

• Oral Candidiasis 100%
• Placebo 27%
• Clotrimazole 27%
• Drug Megadose 18%
• Side Effect 18%
• Ketoconazole 18%
• Radiation Therapy 18%
• Randomized Controlled Trial 9%
• Malignant Neoplasm 9%
• Health Care Cost 9%
• Quality of Life 9%
• Sepsis 9%
• Analgesia 9%
• Random Effects Model 9%
• Cancer Treatment 9%
• Gastrointestinal Tract 9%
• Plummer-Vinson Syndrome 9%
• Diseases 9%